Macrophage PTEN Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses

Abstract

The activation of innate immune cells triggers numerous intracellular signaling pathways, which require tight control to mount an adequate immune response. The PI3K signaling pathway is intricately involved in innate immunity, and its activation dampens the expression and release of proinflammatory cytokines in myeloid cells. These signaling processes are strictly regulated by the PI3K antagonist, the lipid phosphatase, PTEN, a known tumor suppressor. Importantly, PTEN is responsible for the elevated production of cytokines such as IL-6 in response to TLR agonists, and deletion of PTEN results in diminished inflammatory responses. However, the mechanisms by which PI3K negatively regulates TLR signaling are only partially resolved. We observed that Arginase I expression and secretion were markedly induced by PTEN deletion, suggesting PTEN−/− macrophages were alternatively activated. This was mediated by increased expression and activation of the transcription factors C/EBPβ and STAT3. Genetic and pharmacologic experimental approaches in vitro, as well as in vivo autoimmunity models, provide convincing evidence that PI3K/PTEN-regulated extracellular Arginase I acts as a paracrine regulator of inflammation and immunity.

A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue

“…66 In addition, CEBPB is capable of increasing the expression of central nervous system genes such as Choline O-Acetyltransferase (ChAT) that encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. 67 Given the small samples sizes our findings should be followed up in larger cohorts of postmortem brain samples.…”

The functions of tumor suppressor PTEN in innate and adaptive immunity

“…PTEN deletion can induce arginase I expression and secretion by increasing the expression of C/EBPβ and STAT3. 75 In addition, it can enhance GKS3β activation and thus promote an inflammatory response to TLR agonists in macrophages. 73 Kamo et al 76 found that the knockdown of PTEN could promote AKT/β-catenin/Foxol signaling and could down-regulate TLR4 expression in mouse liver cells responding to ischemia/reperfusion injury.…”

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis

“…C57BL/6 mice were immunized at day 0 according to the protocol described recently in Sahin et al (44). Progression of EAE was divided into five clinical stages: score 0, no signs; score 1, complete tail paralysis; score 2, partial paraparesis; score 3, severe paraparesis; score 4, tetraparesis; and score 5, moribund condition.…”